Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01767792
Title Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Alabama at Birmingham
Indications
Therapies

Bevacizumab

Age Groups: adult | child
Covered Countries USA


No variant requirements are available.